Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2017) Theo Vos et al.   LANCET

The fibrinolytic system: A new target for treatment of depression with psychedelics

(2017) R.D. Idell et al.   MEDICAL HYPOTHESES

Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression

(2017) Shih-Jen Tsai   Oncotarget

Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression

(2017) Chanjuan Zhou et al.   PLoS One

Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression

(2017) Or Burstein et al.   PLoS One

Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders

(2016) M A Lebow et al.   MOLECULAR PSYCHIATRY

BDNF – a key transducer of antidepressant effects

(2016) Carl Björkholm et al.   NEUROPHARMACOLOGY

Role of epigenetic factors in the development of mental illness throughout life

(2016) Jerry Guintivano et al.   NEUROSCIENCE RESEARCH

Plasminogen Activator Inhibitor-1 in depression: Results from Animal and Clinical Studies

(2016) Haitang Jiang et al.   Scientific Reports

Major depressive disorder

(2016) Christian Otte et al.   Nature Reviews Disease Primers

BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis

(2015) Maryna Polyakova et al.   JOURNAL OF AFFECTIVE DISORDERS

Antidepressant-like effect of n-3 PUFAs in CUMS rats: role of tPA/PAI-1 system

(2015) Mimi Tang et al.   PHYSIOLOGY & BEHAVIOR

Treatment-resistant depression: are animal models of depression fit for purpose?

(2015) Paul Willner et al.   PSYCHOPHARMACOLOGY

Gene–Environment Interaction in Major Depression: Focus on Experience-Dependent Biological Systems

(2015) Nicola Lopizzo et al.   Frontiers in Psychiatry

Role of Plasminogen Activator Inhibitor-1 in Glucocorticoid-Induced Diabetes and Osteopenia in Mice

(2015) Yukinori Tamura et al.   DIABETES

Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up

(2014) W. W. IsHak et al.   ACTA PSYCHIATRICA SCANDINAVICA

Ventromedial prefrontal cortex regulates depressive-like behavior and rapid eye movement sleep in the rat

(2014) Celene H. Chang et al.   NEUROPHARMACOLOGY

Plasminogen Activator Inhibitor-1 Is Involved in Impaired Bone Repair Associated with Diabetes in Female Mice

(2014) Li Mao et al.   PLoS One

Escitalopram or Novel Herbal Mixture Treatments during or following Exposure to Stress Reduce Anxiety-Like Behavior through Corticosterone and BDNF Modifications

(2014) Ravid Doron et al.   PLoS One

Ethopharmacological analysis of the open elevated plus-maze in mice

(2013) Tatiani Sorregotti et al.   BEHAVIOURAL BRAIN RESEARCH

MAJOR DEPRESSIVE DISORDER IN DSM-5: IMPLICATIONS FOR CLINICAL PRACTICE AND RESEARCH OF CHANGES FROM DSM-IV

(2013) Rudolf Uher et al.   DEPRESSION AND ANXIETY

Increased hippocampal volume and gene expression following cognitive behavioral therapy in PTSD

(2013) Ahmed A. Moustafa   Frontiers in Human Neuroscience

Monoamine neurocircuitry in depression and strategies for new treatments

(2013) Michel Hamon et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Mechanisms of antidepressant resistance

(2013) Wissam El-Hage et al.   Frontiers in Pharmacology

Serotonin transporter gene, stress and raphe–raphe interactions: a molecular mechanism of depression

(2012) Agnes J. Jasinska et al.   TRENDS IN NEUROSCIENCES

Treatment-resistant depression: therapeutic trends, challenges, and future directions

(2012) Al-harbi   Patient Preference and Adherence

Neural circuits underlying the pathophysiology of mood disorders

(2011) Joseph L. Price et al.   TRENDS IN COGNITIVE SCIENCES

Early and Late-Onset Effect of Chronic Stress on Vascular Function in Mice: A Possible Model of the Impact of Depression on Vascular Disease in Aging

(2010) Elsa Isingrini et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Decreased serotonin levels associated with behavioral disinhibition in tissue plasminogen activator deficient (tPA−/−) mice

(2010) Konstantinos Pothakos et al.   BRAIN RESEARCH

The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity

(2010) Eero Castrén et al.   Developmental Neurobiology

Structural brain abnormalities in major depressive disorder: A selective review of recent MRI studies

(2009) Valentina Lorenzetti et al.   JOURNAL OF AFFECTIVE DISORDERS

Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response

(2008) Shih-Jen Tsai et al.   Pharmacogenetics and Genomics

Anti-apoptotic roles of plasminogen activator inhibitor-1 as a neurotrophic factor in the central nervous system

(2008) Satoru Koyanagi et al.   THROMBOSIS AND HAEMOSTASIS